London, UK -- (MARKET WIRE) -- May 1, 2007 --
SKYEPHARMA TO PRESENT AT 2007 UBS GLOBAL
GENERIC & SPECIALTY PHARMACEUTICALS CONFERENCE
LONDON, UK, MAY 1, 2007-- SkyePharma PLC (LSE: SKP; NASDAQ: SKYE) today
announces that the Company's Chief Executive Officer, Frank Condella, will make
a presentation at 2007 UBS Global Generic & Specialty Pharmaceuticals Conference
in New York, USA. Mr Condella will deliver his presentation on Tuesday 8 May
2007 at 4.30 p.m. (GMT). Investors may access a live webcast of the presentation
at
www.skyepharma.com under the Investor Relations tab. The presentation will be
archived for 3 months.
For further information please contact:
SkyePharma PLC
+44 207 491 1777
Frank Condella, Chief Executive Officer
Ken Cunningham, Chief Operating Officer
Peter Grant, Finance Director
Financial Dynamics
+44 207 7831 3113
David Yates
Deborah Scott
The Trout Group
+ 1 617 583 1308
Seth Lewis
About SkyePharma PLC
Using its proprietary drug delivery technologies, SkyePharma develops new
formulations of known molecules to provide a clinical advantage and life-cycle
extension. The Company has ten approved products in the areas of oral,
inhalation and topical delivery that are marketed throughout the world by
leading pharmaceutical companies. For more information, visit
www.skyepharma.com.
This information is provided by RNS
The company news service from the London Stock Exchange